Out-of-pocket costs in gastrointestinal cancer patients: Lack of a perfectly framed problem contributing to financial toxicity.
Cancer
Costs
Financial toxicity
Out-of-pocket
Therapy
Journal
Critical reviews in oncology/hematology
ISSN: 1879-0461
Titre abrégé: Crit Rev Oncol Hematol
Pays: Netherlands
ID NLM: 8916049
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
01
06
2020
revised:
15
08
2021
accepted:
10
10
2021
pubmed:
22
10
2021
medline:
16
11
2021
entrez:
21
10
2021
Statut:
ppublish
Résumé
Fighting cancer is an economically expensive challenge for both health care payers, and the patients and their families and the median costs for cancer care are rapidly increasing in the last decade. Although both direct and indirect costs of medical assistance have been a frequent source of distress and contention, however analysis of the non-medical expenses incurred directly by cancer patients has not received adequate attention. Developing a deeper understanding of so-called "out-of-pocket" costs may be necessary. Out-of-pocket costs for medical care range from 7 % to 11 % of medical costs for all payers. However, the range of out-of-pocket costs shows considerable variability in different studies. In this review, we reviewed available data concerning direct and indirect medical costs, including psychosocial ones.
Identifiants
pubmed: 34673219
pii: S1040-8428(21)00288-2
doi: 10.1016/j.critrevonc.2021.103501
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103501Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.